作者:
Cranage, Martin P. [1]
;
Fraser, Carol A. [2]
;
Cope, Alethea [3]
;
McKay, Paul F. [4]
;
Seaman, Michael S. ;
Cole, Tom ;
Mahmoud, A. Nasir ;
Hall, Joanna ;
Giles, Elaine ;
Voss, Gerald ;
Page, Mark ;
Almond, Neil ;
Shattock, Robin J. .
作者单位:
GlaxoSmithKline Biologicals, Rixensart, Belgium
[1]
CAVD Neutralizing Antibody Laboratory, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
[2]
Centre for Infection and Immunity, Division of Clinical Sciences, St George’s, University of London, Cranmer Terrace, London SW17 0RE, UK
[3]
Division of Retrovirology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, UK
[4]
发布时间
2014-01-15